ARTICLE | Data Byte

As policy pressure appears to ease, WuXi AppTec, WuXi Biologics shares rise

News from the White House, Congress suggests they won’t be driven out of the U.S.

March 4, 2024 8:10 PM UTC

Shares in WuXi AppTec and WuXi Biologics gained 13% and 12%, respectively, Monday, buoyed by an executive order protecting genomic privacy that doesn’t target the companies.

As BioCentury reported Friday, the Executive Order on Preventing Access to Americans’ Bulk Sensitive Personal Data and United States Government-Related Data by Countries of Concern, could reduce pressure on Democrats to endorse sweeping anti-China biotech bills that specifically target WuXi AppTec Co. Ltd. (Shanghai:603259; HKEX:2359) and WuXi Biologics Inc. (HKEX:2269)...